Active Ingredient History

NOW
  • Now
Nabumetone is a naphthylalkanone. Is is a non-selective prostaglandin G/H synthase (a.k.a. cyclooxygenase or COX) inhibitor that acts on both prostaglandin G/H synthase 1 and 2 (COX-1 and -2). Prostaglandin G/H synthase catalyzes the conversion of arachidonic acid to prostaglandin G2 and prostaglandin G2 to prostaglandin H2. Prostaglandin H2 is the precursor to a number of prostaglandins involved in fever, pain, swelling, inflammation, and platelet aggregation. The parent compound is a prodrug that undergoes hepatic biotransformation to the active compound, 6-methoxy-2-naphthylacetic acid (6MNA). The analgesic, antipyretic and anti-inflammatory effects of NSAIDs occur as a result of decreased prostaglandin synthesis. The parent compound is a prodrug, which undergoes hepatic biotransformation to the active component, 6-methoxy-2-naphthylacetic acid (6MNA), that is a potent inhibitor of prostaglandin synthesis, most likely through binding to the COX-2 and COX-1 receptors. Nabumetone is used for acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis. Nabumetone has been developed by Beecham. It is available under numerous brand names, such as Relafen, Relifex, and Gambaran.   NCATS

  • SMILES: COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
  • InChIKey: BLXXJMDCKKHMKV-UHFFFAOYSA-N
  • Mol. Mass: 228.2863
  • ALogP: 3.37
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: Yes

Drug Pricing (per unit)

United States

$0.2305 - $0.4299
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

4-(6-methoxy-2-naphthalenyl)-2-butanone | 4-(6-methoxy-2-naphthyl)-2-butanone | apo-nabumetone | arthraxan | brl 14777 | brl-14777 | gen-nabumetone | listran | mebutan | nabucox | nabumeton | nabumetona | nabumetone | nabumétone | nabumetonum | nabuton | relafen | relif | relifex | rhoxal-nabumetone

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue